|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Union
Carbide Corporation and Subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
|
|
Sept.
30,
|
|
|
Sept.
30,
|
|
Sept.
30,
|
|
|
Sept.
30,
|
|
In
millions (Unaudited)
|
|
2009
|
|
|
2008
|
|
2009
|
|
|
2008
|
|
Net
trade sales
|
|
$
|
35
|
|
|
$
|
48
|
|
|
$
|
113
|
|
|
$
|
144
|
|
Net
sales to related companies
|
|
|
1,322
|
|
|
|
1,929
|
|
|
|
3,573
|
|
|
|
5,823
|
|
Total
Net Sales
|
|
$
|
1,357
|
|
|
$
|
1,977
|
|
|
$
|
3,686
|
|
|
$
|
5,967
|
|
Cost
of sales
|
|
|
1,145
|
|
|
|
1,942
|
|
|
|
3,224
|
|
|
|
5,785
|
|
Research
and development expenses
|
|
|
10
|
|
|
|
16
|
|
|
|
37
|
|
|
|
54
|
|
Selling,
general and administrative expenses
|
|
|
1
|
|
|
|
3
|
|
|
|
7
|
|
|
|
9
|
|
Restructuring
charges
|
|
|
-
|
|
|
|
-
|
|
|
|
166
|
|
|
|
-
|
|
Equity
in earnings of nonconsolidated affiliates
|
|
|
14
|
|
|
|
55
|
|
|
|
20
|
|
|
|
172
|
|
Sundry
income (expense) - net
|
|
|
320
|
|
|
|
(18
|
)
|
|
|
322
|
|
|
|
38
|
|
Interest
income
|
|
|
21
|
|
|
|
24
|
|
|
|
31
|
|
|
|
82
|
|
Interest
expense and amortization of debt discount
|
|
|
8
|
|
|
|
12
|
|
|
|
32
|
|
|
|
37
|
|
Income
before Income Taxes
|
|
$
|
548
|
|
|
$
|
65
|
|
|
$
|
593
|
|
|
$
|
374
|
|
Provision
(credit) for income taxes
|
|
|
222
|
|
|
|
(16
|
)
|
|
|
183
|
|
|
|
93
|
|
Net
Income Attributable to Union Carbide Corporation
|
|
$
|
326
|
|
|
$
|
81
|
|
|
$
|
410
|
|
|
$
|
281
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
|
|
$
|
63
|
|
|
$
|
66
|
|
|
$
|
201
|
|
|
$
|
197
|
|
Capital
Expenditures
|
|
$
|
21
|
|
|
$
|
74
|
|
|
$
|
62
|
|
|
$
|
173
|
|
See
Notes to the Consolidated Financial Statements.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Union
Carbide Corporation and Subsidiaries
|
|
|
|
|
|
|
|
|
|
|
Sept.
30,
|
|
Dec.
31,
|
In
millions (Unaudited)
|
|
2009
|
|
2008
|
Assets
|
|
|
|
|
|
|
Current
Assets
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$
|
15
|
|
|
$
|
24
|
|
Accounts
receivable:
|
|
|
|
|
|
|
|
|
Trade
(net of allowance for doubtful receivables - 2009: $1; 2008:
$1)
|
|
|
20
|
|
|
|
21
|
|
Related
companies
|
|
|
284
|
|
|
|
128
|
|
Other
|
|
|
87
|
|
|
|
90
|
|
Notes
receivable from related companies
|
|
|
4,562
|
|
|
|
3,934
|
|
Inventories
|
|
|
193
|
|
|
|
187
|
|
Other
current assets and deferred income taxes
|
|
|
72
|
|
|
|
64
|
|
Total
current assets
|
|
|
5,233
|
|
|
|
4,448
|
|
Investments
|
|
|
|
|
|
|
|
|
Investments
in related companies
|
|
|
972
|
|
|
|
972
|
|
Investments
in nonconsolidated affiliates
|
|
|
100
|
|
|
|
427
|
|
Other
investments
|
|
|
24
|
|
|
|
19
|
|
Noncurrent
receivables
|
|
|
46
|
|
|
|
46
|
|
Noncurrent
receivables from related companies
|
|
|
192
|
|
|
|
187
|
|
Total
investments
|
|
|
1,334
|
|
|
|
1,651
|
|
Property
|
|
|
|
|
|
|
|
|
Property
|
|
|
7,513
|
|
|
|
7,630
|
|
Less
accumulated depreciation
|
|
|
5,941
|
|
|
|
5,744
|
|
Net
property
|
|
|
1,572
|
|
|
|
1,886
|
|
Other
Assets
|
|
|
|
|
|
|
|
|
Other
intangible assets (net of accumulated amortization 2009: $139; 2008:
$135)
|
|
|
11
|
|
|
|
17
|
|
Deferred
income tax assets - noncurrent
|
|
|
381
|
|
|
|
439
|
|
Asbestos-related
insurance receivables - noncurrent
|
|
|
618
|
|
|
|
658
|
|
Deferred
charges and other assets
|
|
|
74
|
|
|
|
79
|
|
Total
other assets
|
|
|
1,084
|
|
|
|
1,193
|
|
Total
Assets
|
|
$
|
9,223
|
|
|
$
|
9,178
|
|
Liabilities
and Equity
|
|
|
|
|
|
|
|
|
Current
Liabilities
|
|
|
|
|
|
|
|
|
Notes
payable - related companies
|
|
$
|
2
|
|
|
$
|
12
|
|
Long-term
debt due within one year
|
|
|
-
|
|
|
|
249
|
|
Accounts
payable:
|
|
|
|
|
|
|
|
|
Trade
|
|
|
194
|
|
|
|
170
|
|
Related
companies
|
|
|
239
|
|
|
|
299
|
|
Other
|
|
|
32
|
|
|
|
35
|
|
Income
taxes payable
|
|
|
253
|
|
|
|
176
|
|
Asbestos-related
liabilities - current
|
|
|
110
|
|
|
|
120
|
|
Accrued
and other current liabilities
|
|
|
197
|
|
|
|
198
|
|
Total
current liabilities
|
|
|
1,027
|
|
|
|
1,259
|
|
Long-Term
Debt
|
|
|
571
|
|
|
|
571
|
|
Other
Noncurrent Liabilities
|
|
|
|
|
|
|
|
|
Pension
and other postretirement benefits - noncurrent
|
|
|
611
|
|
|
|
662
|
|
Asbestos-related
liabilities - noncurrent
|
|
|
757
|
|
|
|
824
|
|
Other
noncurrent obligations
|
|
|
282
|
|
|
|
298
|
|
Total
other noncurrent liabilities
|
|
|
1,650
|
|
|
|
1,784
|
|
Stockholder's
Equity
|
|
|
|
|
|
|
|
|
Common
stock (authorized and issued: 1,000 shares of $0.01 par value
each)
|
|
|
-
|
|
|
|
-
|
|
Additional
paid-in capital
|
|
|
312
|
|
|
|
312
|
|
Retained
earnings
|
|
|
6,504
|
|
|
|
6,094
|
|
Accumulated
other comprehensive loss
|
|
|
(842
|
)
|
|
|
(844
|
)
|
Union
Carbide Corporation's stockholder's equity
|
|
|
5,974
|
|
|
|
5,562
|
|
Noncontrolling
interests
|
|
|
1
|
|
|
|
2
|
|
Total
equity
|
|
|
5,975
|
|
|
|
5,564
|
|
Total
Liabilities and Equity
|
|
$
|
9,223
|
|
|
$
|
9,178
|
|
See
Notes to the Consolidated Financial Statements.
|
|
|
|
|
|
|
|
|
Union
Carbide Corporation and Subsidiaries
|
|
|
|
|
|
|
|
|
|
|
Nine
Months Ended
|
|
|
Sept.
30,
|
|
Sept.
30,
|
In
millions (Unaudited)
|
|
2009
|
|
2008
|
Operating
Activities
|
|
|
|
|
|
|
Net
Income Attributable to Union Carbide Corporation
|
|
$
|
410
|
|
|
$
|
281
|
|
Adjustments
to reconcile net income to net cash provided by (used in) operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
219
|
|
|
|
204
|
|
Provision
(credit) for deferred income tax
|
|
|
(9
|
)
|
|
|
113
|
|
Earnings
of nonconsolidated affiliates less than (in excess of) dividends
received
|
|
|
7
|
|
|
|
(136
|
)
|
Net
gain on sales of property
|
|
|
(3
|
)
|
|
|
(7
|
)
|
Restructuring
charges
|
|
|
166
|
|
|
|
-
|
|
Other
gain, net
|
|
|
(4
|
)
|
|
|
-
|
|
Gain
on sale of ownership interest in nonconsolidated
affiliates
|
|
|
(328
|
)
|
|
|
-
|
|
Pension
contribution
|
|
|
(1
|
)
|
|
|
(2
|
)
|
Changes
in assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
and notes receivable
|
|
|
(41
|
)
|
|
|
(6
|
)
|
Related
company receivables
|
|
|
(784
|
)
|
|
|
(263
|
)
|
Inventories
|
|
|
(6
|
)
|
|
|
(44
|
)
|
Accounts
payable
|
|
|
36
|
|
|
|
27
|
|
Related
company payables
|
|
|
(70
|
)
|
|
|
(1
|
)
|
Other
assets and liabilities
|
|
|
47
|
|
|
|
(24
|
)
|
Cash
provided by (used in) operating activities
|
|
|
(361
|
)
|
|
|
142
|
|
Investing
Activities
|
|
|
|
|
|
|
|
|
Capital
expenditures
|
|
|
(62
|
)
|
|
|
(173
|
)
|
Proceeds
from sale of ownership interest in nonconsolidated
affiliates
|
|
|
660
|
|
|
|
-
|
|
Changes
in noncurrent receivable from related company
|
|
|
(5
|
)
|
|
|
29
|
|
Proceeds
from sales of property
|
|
|
6
|
|
|
|
6
|
|
Purchases
of investments
|
|
|
(17
|
)
|
|
|
(12
|
)
|
Proceeds
from sales of investments
|
|
|
19
|
|
|
|
11
|
|
Cash
provided by (used in) investing activities
|
|
|
601
|
|
|
|
(139
|
)
|
Financing
Activities
|
|
|
|
|
|
|
|
|
Payments
on long-term debt
|
|
|
(249
|
)
|
|
|
-
|
|
Cash
used in financing activities
|
|
|
(249
|
)
|
|
|
-
|
|
Summary
|
|
|
|
|
|
|
|
|
Increase
(decrease) in cash and cash equivalents
|
|
|
(9
|
)
|
|
|
3
|
|
Cash
and cash equivalents at beginning of year
|
|
|
24
|
|
|
|
22
|
|
Cash
and cash equivalents at end of period
|
|
$
|
15
|
|
|
$
|
25
|
|
See
Notes to the Consolidated Financial Statements.
|
|
|
|
|
|
|
|
|
Union
Carbide Corporation and Subsidiaries
|
|
|
|
|
|
|
|
|
|
Nine
Months Ended
|
|
|
|
Sept.
30,
|
Sept.
30,
|
In
millions (Unaudited)
|
|
|
2009
|
2008
|
Common
Stock
|
|
|
|
|
Balance
at beginning of year and end of period
|
|
|
-
|
-
|
Additional
Paid-in Capital
|
|
|
|
|
Balance
at beginning of year
|
|
$
|
312
|
$ 121
|
Capital
contribution
|
|
|
-
|
191
|
Balance
at end of period
|
|
|
312
|
312
|
Retained
Earnings
|
|
|
|
|
Balance
at beginning of year
|
|
|
6,094
|
5,767
|
Net
income
|
|
|
410
|
281
|
Other
|
|
|
-
|
1
|
Balance
at end of period
|
|
|
6,504
|
6,049
|
Accumulated
Other Comprehensive Loss, Net of Tax
|
|
|
|
|
Cumulative
Translation Adjustments at beginning of year
|
|
|
(61)
|
(69)
|
Translation
adjustments
|
|
|
1
|
1
|
Balance
at end of period
|
|
|
(60)
|
(68)
|
Pension
and Other Postretirement Benefit Plans at beginning of
year
|
|
|
(783)
|
(164)
|
Adjustments
to pension and other postretirement benefit plans
|
|
|
-
|
4
|
Pension
and Other Postretirement Benefit Plans at end of period
|
|
|
(783)
|
(160)
|
Accumulated
Investment Gain at beginning of year and end of period
|
|
|
1
|
-
|
Accumulated
Derivative Gain at beginning of year
|
|
|
(1)
|
-
|
Net
hedging results
|
|
|
1
|
(1)
|
Balance
at end of period
|
|
|
-
|
(1)
|
Total
accumulated other comprehensive loss
|
|
|
(842)
|
(229)
|
Union
Carbide Corporation's Stockholder's Equity
|
|
|
5,974
|
6,132
|
Noncontrolling
Interests
|
|
|
1
|
2
|
Total
Equity
|
|
$
|
5,975
|
$ 6,134
|
See
Notes to the Consolidated Financial Statements.
|
|
|
|
|
Union
Carbide Corporation and Subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
|
Sept.
30,
|
|
|
Sept.
30,
|
|
Sept.
30,
|
|
|
Sept.
30,
|
In
millions (Unaudited)
|
|
2009
|
|
|
2008
|
|
2009
|
|
|
2008
|
Net
Income Attributable to Union Carbide Corporation
|
|
$
|
326
|
|
|
$
|
81
|
|
|
$
|
410
|
|
|
$
|
281
|
|
Other
Comprehensive Income, Net of Tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Translation
adjustments
|
|
$
|
4
|
|
|
$
|
(1
|
)
|
|
$
|
1
|
|
|
$
|
1
|
|
Adjustments
to pension and other postretirement benefit plans
|
|
|
1
|
|
|
|
1
|
|
|
|
-
|
|
|
|
4
|
|
Net
gain (loss) on cash flow hedging derivative instruments
|
|
|
1
|
|
|
|
-
|
|
|
|
1
|
|
|
|
(1
|
)
|
Total
other comprehensive income
|
|
|
6
|
|
|
|
-
|
|
|
|
2
|
|
|
|
4
|
|
Comprehensive
Income
|
|
$
|
332
|
|
|
$
|
81
|
|
|
$
|
412
|
|
|
$
|
285
|
|
See
Notes to the Consolidated Financial Statements.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Union
Carbide Corporation and Subsidiaries
NOTE
A CONSOLIDATED FINANCIAL STATEMENTS
The
unaudited interim consolidated financial statements of Union Carbide Corporation
and its subsidiaries (the “Corporation” or “UCC”) were prepared in accordance
with accounting principles generally accepted in the United States of America
(“GAAP”) and reflect all adjustments (including normal recurring accruals)
which, in the opinion of management, are considered necessary for the fair
presentation of the results for the periods presented.
The
Corporation is a wholly owned subsidiary of The Dow Chemical Company (“Dow”). In
accordance with the accounting guidance for earnings per share, the presentation
of earnings per share is not required in financial statements of wholly owned
subsidiaries.
The
Corporation’s business activities comprise components of Dow’s global operations
rather than stand-alone operations. Dow conducts its worldwide operations
through global businesses. Because there are no separable reportable business
segments for UCC under the accounting guidance related to segment reporting and
no detailed business information is provided to a chief operating decision maker
regarding the Corporation’s stand-alone operations, the Corporation’s results
are reported as a single operating segment.
Intercompany
transactions and balances are eliminated in consolidation. Transactions with the
Corporation’s parent company, Dow, and other Dow subsidiaries have been
reflected as related company transactions in the consolidated financial
statements. See Note K for further discussion.
These
statements should be read in conjunction with the audited consolidated financial
statements and notes thereto included in the Corporation’s Annual Report on Form
10-K for the year ended December 31, 2008.
NOTE
B RECENT ACCOUNTING GUIDANCE
Accounting
Standards Codification
On
July 1, 2009, the Financial Accounting Standards Board (“FASB”) Accounting
Standards Codification
™
(“Codification” or “ASC”) became the single source of authoritative GAAP (other
than rules and interpretive releases of the U.S. Securities and Exchange
Commission). The Codification is topically based with topics organized by ASC
number and updated with Accounting Standards Updates (“ASUs”). ASUs will replace
accounting guidance that historically was issued as FASB Statements (“SFAS”),
FASB Interpretations (“FIN”), FASB Staff Positions (“FSP”), Emerging Issue Task
Force (“EITF”) Issues or other types of accounting standards. The Codification
became effective September 30, 2009 for the Corporation and disclosures
within this Quarterly Report on Form 10-Q have been updated to reflect the
change.
Accounting
for Noncontrolling Interests
SFAS
No. 160, “Noncontrolling Interests in Consolidated Financial Statements – an
amendment of ARB No. 51” (codified in ASC Topic 810, “Consolidation”), was
effective January 1, 2009 for the Corporation and established accounting
and reporting standards for noncontrolling interests in a subsidiary and for
deconsolidation of a subsidiary. The retrospective presentation and disclosure
requirements outlined by the consolidation guidance have been incorporated into
this Quarterly Report on Form 10-Q for the interim period ended
September 30, 2009.
Fair
Value Measurements
On
January 1, 2009, the Corporation adopted FSP No. FAS 157-2, “Effective
Date of FASB Statement No. 157” (codified in ASC Topic 820, “Fair Value
Measurements and Disclosures”), related to nonfinancial assets and nonfinancial
liabilities that are not recognized or disclosed at fair value on the financial
statements on a recurring basis. Since the Corporation’s fair value measurements
for nonfinancial assets and nonfinancial liabilities were consistent with the
guidance, the adoption of the guidance did not have a material impact on the
Corporation’s consolidated financial statements. The required disclosures are
included in Note H.
On
June 30, 2009, the Corporation adopted FSP No. FAS 157-4, “Determining Fair
Value When the Volume and Level of Activity for the Asset or Liability Have
Significantly Decreased and Identifying Transactions That Are Not Orderly”
(codified in ASC Topic 820). This FSP provides additional guidance for
estimating the fair value when the market activity for an asset or liability has
declined significantly. The adoption of this guidance did not have a material
impact on the Corporation’s consolidated financial statements.
On
June 30, 2009, the Corporation adopted FSP No. FAS 107-1 and APB 28-1,
“Interim Disclosures about Fair Value of Financial Instruments,” (codified in
ASC Topic 270, “Interim Reporting”). This guidance requires disclosures about
the fair value of financial instruments during interim reporting periods. The
Corporation’s enhanced disclosures are included in Note G.
On
August 28, 2009, the FASB issued ASU 2009-05, “Measuring Liabilities
at Fair Value,” to provide guidance on measuring the fair value of liabilities
under ASC 820. This ASU clarifies the fair value measurements for a
liability in an
active
market and the valuation techniques in the absence of a Level 1 measurement.
This ASU is effective for the first reporting period (including interim periods)
beginning after issuance, which is October 1, 2009 for the Corporation. The
adoption of this ASU is not anticipated to have a material impact on the
Corporation’s consolidated financial statements.
Other
Recently Adopted Accounting Guidance
On
January 1, 2009, the Corporation adopted SFAS No. 161, “Disclosures
about Derivative Instruments and Hedging Activities - an amendment of FASB
Statement No. 133” (codified in ASC Topic 815, “Derivatives and Hedging”).
This guidance requires enhanced disclosures about an entity’s derivative and
hedging activities. The Corporation’s disclosures are included in
Note G.
On
January 1, 2009, the Corporation adopted FSP No. FAS 141(R)-1, “Accounting
for Assets Acquired and Liabilities Assumed in a Business Combination That Arise
from Contingencies” (codified in ASC Topic 805, “Business Combinations” and
ASC Topic 820), related to assets acquired and liabilities assumed in a business
combination that arise from contingencies. This guidance states that assets
acquired and liabilities assumed in a business combination that arise from
contingencies should be recognized at fair value, if the acquisition date fair
value can be reasonably determined. If the acquisition date fair value cannot be
reasonably determined, then the asset or liability should be recognized in
accordance with ASC Topic 450, “Contingencies” (formerly SFAS No. 5,
“Accounting for Contingencies,” and FIN No. 14, “Reasonable Estimation
of the Amount of a Loss - an interpretation of FASB Statement No. 5”). This
guidance also requires new disclosures for the assets and liabilities within the
scope of this guidance. The Corporation will apply this guidance to future
business combinations.
On
June 30, 2009 the Corporation adopted FSP No. FAS 115-2 and
FAS 124-2, “Recognition and Presentation of Other-Than-Temporary
Impairments” (codified in ASC Topic 320, “Investments - Debt and
Equity Securities”). This guidance amends the other-than-temporary impairment
guidance for debt securities to make the guidance more operational and to
improve the presentation and disclosure of other-than-temporary impairments on
debt and equity securities. The adoption of this guidance did not have a
material impact on the Corporation’s consolidated financial
statements.
On
June 30, 2009 the Corporation adopted SFAS No. 165, “Subsequent Events”
(codified in ASC Topic 855, “Subsequent Events”). This guidance establishes the
principles and requirements for evaluating and reporting subsequent events,
including the period subject to evaluation for subsequent events, the
circumstances requiring recognition of subsequent events in the financial
statements, and the required disclosures. The Corporation has evaluated
subsequent events in accordance with this guidance through the filing of this
Quarterly Report on Form 10-Q on October 30, 2009.
Accounting
Guidance Issued But Not Yet Adopted
In
December 2008, the FASB issued FSP No. FAS 132(R)-1, “Employers’
Disclosures about Postretirement Benefit Plan Assets” (codified in ASC Topic
715, “Compensation-Retirement Benefits”). The guidance requires new disclosures
on investment policies and strategies, categories of plan assets, fair value
measurements of plan assets, and significant concentrations of risk, and is
effective for fiscal years ending after December 15, 2009, with earlier
application permitted. The Corporation will include the required disclosures in
the Corporation’s Annual Report on Form 10-K for the annual period ending
December 31, 2009.
On
January 1, 2010, the Corporation will be required to follow the new
disclosure guidance in SFAS No. 166, “Accounting for Transfers of Financial
Assets – an amendment of FASB Statement No. 140” (codified in ASC Topic 860,
“Transfers and Servicing”), related to transfers of assets. This guidance is
intended to improve the information provided in financial statements concerning
transfers of financial assets, including the effects of transfers on financial
position, financial performance and cash flows, and any continuing involvement
of the transferor with the transferred financial assets. The Corporation is
currently evaluating the impact of adopting the guidance.
In
June 2009, the FASB issued SFAS No. 167, “Amendments to FASB Interpretation
No. 46(R),” which amends the consolidation guidance applicable to variable
interest entities and requires additional disclosures concerning an enterprise’s
continuing involvement with variable interest entities. The Statement is
effective for annual periods beginning after November 15, 2009, which is
January 1, 2010 for the Corporation, and interim periods within that annual
reporting period. The Corporation is currently evaluating the impact of adopting
the Statement on January 1, 2010.
In
September 2009, the FASB ratified the consensus reached by the EITF with respect
to EITF Issue No. 08-1, “Revenue Arrangements with Multiple Deliverables,”
which amends the criteria for when to evaluate individual delivered items in a
multiple deliverable arrangement and how to allocate consideration received.
This Issue is effective for fiscal periods beginning on or after June 15,
2010, which is January 1, 2011 for the Corporation. The Corporation is
currently evaluating the impact of adopting the guidance.
In
September 2009, the FASB ratified the consensus reached by the EITF with respect
to EITF Issue No. 09-3, “Applicability of Statement of Position 97-2
to Certain Arrangements that Include Software Elements” which clarifies the
accounting guidance for sales of tangible products containing both software and
hardware elements. This Issue is effective
for
fiscal periods beginning on or after June 15, 2010, which is
January 1, 2011 for the Corporation. The Corporation is currently
evaluating the impact of adopting the guidance.
NOTE
C RESTRUCTURING
2009
Restructuring
On
June 30, 2009, the Board of Directors of UCC approved a restructuring plan to
improve the cost effectiveness of the Corporation’s global operations. As a
result, the Corporation recorded restructuring charges of $162 million in
the second quarter of 2009, which included the shutdown of certain facilities
that produce ethylene as well as ethylene oxide/ethylene glycol in Hahnville,
Louisiana ($38 million) and certain related capital project write-offs
($7 million). In addition, due to the expected loss arising from the United
States Federal Trade Commission (“FTC”) required divestiture of certain
specialty latex assets resulting from Dow’s acquisition of Rohm and Haas
Company, the Corporation recognized an impairment charge in the second quarter
of 2009 ($114 million). Included in the second quarter restructuring charge
was severance of approximately $3 million for 41 people related to the
plant shutdowns and corporate workforce reductions. During the third quarter of
2009, severance of $2 million was paid, leaving a liability of
$1 million at September 30, 2009 for 16 people.
The
following table summarizes the activities related to the Corporation’s
restructuring reserve:
2009
Restructuring Activities
In
millions
|
|
Impairment
of Long-Lived Assets and Other Assets
|
|
Severance
Costs
|
|
Total
|
Restructuring
charges recognized in the second quarter of 2009
|
|
$
|
159
|
|
|
$
|
3
|
|
|
$
|
162
|
|
Charges
against reserve
|
|
|
(159
|
)
|
|
|
-
|
|
|
|
(159
|
)
|
Reserve
balance at June 30, 2009
|
|
|
-
|
|
|
$
|
3
|
|
|
$
|
3
|
|
Cash
payments
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
(2
|
)
|
Reserve
balance at September 30, 2009
|
|
|
-
|
|
|
$
|
1
|
|
|
$
|
1
|
|
2008
Restructuring
On
December 5, 2008, the Board of Directors of UCC approved a restructuring
plan to improve the cost effectiveness of the Corporation’s global operations.
As a result, the Corporation recorded restructuring charges of $105 million
in the fourth quarter of 2008, which included the write-off of the net book
value of certain assets in Texas and Xiaolan, China, and a workforce reduction
to improve the cost effectiveness and to enhance the efficiency of the
Corporation’s operations. The charges included a $57 million write-off of
the net book value associated with the shutdown of a facility that manufactures
NORDEL
TM
hydrocarbon rubber in Seadrift, Texas, the solution vinyl resins facility in
Texas City, Texas and the emulsion systems facility in Xiaolan, China; severance
of $24 million for a workforce reduction of 399 people; and
curtailment costs of $24 million associated with the Corporation’s defined
benefit plans. During the first quarter of 2009, the Corporation identified an
additional 50 employees to be separated under the 2008 restructuring plan,
resulting in the recognition of an additional $4 million of severance cost.
During the first nine months of 2009, severance of $22 million was paid,
leaving a liability at September 30, 2009 of $6 million for approximately
100 employees. The workforce reduction is expected to be completed by the
end of 2010.
The
following table summarizes the 2009 activities related to the Corporation’s 2008
restructuring reserve:
2009
Activities Related to 2008 Restructuring
In
millions
|
|
Costs
associated with Exit or
Disposal
Activities
|
|
|
Severance
Costs
|
|
Total
|
Reserve
balance at December 31, 2008
|
|
$
|
24
|
|
|
$
|
24
|
|
|
$
|
48
|
|
Adjustment
to the reserve
|
|
|
-
|
|
|
|
4
|
|
|
|
4
|
|
Cash
payments
|
|
|
-
|
|
|
|
(8
|
)
|
|
|
(8
|
)
|
Reserve
balance at March 31, 2009
|
|
$
|
24
|
|
|
$
|
20
|
|
|
$
|
44
|
|
Cash
payments
|
|
|
-
|
|
|
|
(10
|
)
|
|
|
(10
|
)
|
Reserve
balance at June 30, 2009
|
|
$
|
24
|
|
|
$
|
10
|
|
|
$
|
34
|
|
Cash
payments
|
|
|
-
|
|
|
|
(4
|
)
|
|
|
(4
|
)
|
Reserve
balance at September 30, 2009
|
|
$
|
24
|
|
|
$
|
6
|
|
|
$
|
30
|
|
2007
Restructuring
On
November 30, 2007, the Board of Directors of UCC approved a plan to shut
down certain assets and make organizational changes to enhance the efficiency
and cost effectiveness of the Corporation's operations. As a result, based on
decisions made by management, the Corporation recorded restructuring charges of
$55 million in the fourth quarter of 2007. The charges included a
$26 million write-off of the net book value of the polypropylene
manufacturing facility at St. Charles Operations in Hahnville, Louisiana,
which was shut down at the end of 2007; severance of $17 million for a
workforce reduction of 231 people; and curtailment costs of
$12 million associated with the Corporation’s defined benefit pension
plans. At December 31, 2008, severance of $2 million had been paid and
a liability of $15 million remained for 187 employees. In the first
nine months of 2009, severance of $6 million was paid, leaving a liability
at September 30, 2009 of $9 million for approximately
67 employees. The workforce reduction is expected to be completed by
December 31, 2009.
The
following table summarizes the 2009 activities related to the Corporation’s 2007
restructuring reserve:
2009
Activities Related to 2007 Restructuring
In
millions
|
|
Costs
associated with Exit or
Disposal
Activities
|
|
|
Severance
Costs
|
|
Total
|
Reserve
balance at December 31, 2008
|
|
$
|
12
|
|
|
$
|
15
|
|
|
$
|
27
|
|
Cash
payments
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
(2
|
)
|
Reserve
balance at March 31, 2009
|
|
$
|
12
|
|
|
$
|
13
|
|
|
$
|
25
|
|
Cash
payments
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
(1
|
)
|
Reserve
balance at June 30, 2009
|
|
$
|
12
|
|
|
$
|
12
|
|
|
$
|
24
|
|
Cash
payments
|
|
|
-
|
|
|
|
(3
|
)
|
|
|
(3
|
)
|
Reserve
balance at September 30, 2009
|
|
$
|
12
|
|
|
$
|
9
|
|
|
$
|
21
|
|
NOTE
D DIVESTITURE OF NONCONSOLIDATED
AFFILIATES
On
September 30, 2009, the Corporation completed the sale of its ownership
interest in the OPTIMAL Group of Companies (“OPTIMAL”), nonconsolidated
affiliates, for $660 million This resulted in a pretax gain of
$328 million included in “Sundry income (expense) - net.”
NOTE
E INVENTORIES
The
following table provides a breakdown of inventories:
Inventories
In
millions
|
|
Sept.
30,
2009
|
|
|
Dec.
31,
2008
|
|
Finished
goods
|
|
$
|
58
|
|
|
$
|
48
|
|
Work
in process
|
|
|
11
|
|
|
|
10
|
|
Raw
materials
|
|
|
45
|
|
|
|
55
|
|
Supplies
|
|
|
79
|
|
|
|
74
|
|
Total
inventories
|
|
$
|
193
|
|
|
$
|
187
|
|
The
reserves reducing inventories from the first-in, first-out (“FIFO”) basis to the
last-in, first-out (“LIFO”) basis amounted to $100 million at September 30,
2009 and $115 million at December 31, 2008.
NOTE
F OTHER INTANGIBLE ASSETS
The
following table provides information regarding the Corporation’s other
intangible assets:
Other
Intangible Assets
|
|
At
September 30, 2009
|
|
|
At
December 31, 2008
|
|
In
millions
|
|
Gross
Carrying Amount
|
|
|
Accumulated
Amortization
|
|
|
Net
|
|
|
Gross
Carrying Amount
|
|
|
Accumulated
Amortization
|
|
|
Net
|
|
Intangible
assets with finite lives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Licenses
and intellectual property
|
|
$
|
33
|
|
|
$
|
(33
|
)
|
|
|
-
|
|
|
$
|
33
|
|
|
$
|
(33
|
)
|
|
|
-
|
|
Patents
|
|
|
2
|
|
|
|
(1
|
)
|
|
$
|
1
|
|
|
|
2
|
|
|
|
(1
|
)
|
|
$
|
1
|
|
Software
|
|
|
115
|
|
|
|
(105
|
)
|
|
|
10
|
|
|
|
117
|
|
|
|
(101
|
)
|
|
|
16
|
|
Total
other intangible assets
|
|
$
|
150
|
|
|
$
|
(139
|
)
|
|
$
|
11
|
|
|
$
|
152
|
|
|
$
|
(135
|
)
|
|
$
|
17
|
|
Amortization
expense for software, which is included in “Cost of sales,” was $1 million
in the third quarter of 2009 and $2 million in the third quarter of 2008.
Amortization expense for software was $4 million for the nine months ended
September 30, 2009 and $5 million for the nine months ended
September 30, 2008. Amortization expense for other intangible assets (not
including software) was immaterial in the third quarters of 2009 and 2008 as
well as for the first nine months of 2009 and 2008. Total estimated amortization
expense for 2009 and the five succeeding fiscal years is as
follows:
Estimated
Amortization Expense
In
millions
|
|
2009
|
|
$
|
6
|
|
2010
|
|
$
|
5
|
|
2011
|
|
$
|
4
|
|
2012
|
|
$
|
2
|
|
2013
|
|
|
-
|
|
2014
|
|
|
-
|
|
NOTE
G FINANCIAL INSTRUMENTS
The
Corporation’s investments in marketable securities are classified as
available-for-sale.
Investing
Results
In millions
|
|
Nine
Months Ended Sept. 30, 2009
|
|
Proceeds
from sales of available-for-sale securities
|
|
$
|
5
|
|
The
Corporation’s investments in debt securities had contractual maturities of less
than 10 years.
Fair
Value of Financial Instruments:
|
|
|
|
At
September 30, 2009
|
|
|
At
December 31, 2008
|
|
In
millions
|
|
Cost
|
|
Gain
|
|
|
Loss
|
|
|
Fair
Value
|
|
Cost
|
|
Gain
|
|
|
Loss
|
|
|
Fair
Value
|
Marketable
securities
(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt
securities
|
|
$
|
19
|
|
|
$
|
1
|
|
|
|
-
|
|
|
$
|
20
|
|
|
$
|
13
|
|
|
$
|
1
|
|
|
|
-
|
|
|
$
|
14
|
|
Equity
securities
|
|
|
1
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Total
marketable securities
|
|
$
|
20
|
|
|
$
|
1
|
|
|
|
-
|
|
|
$
|
21
|
|
|
$
|
13
|
|
|
$
|
1
|
|
|
|
-
|
|
|
$
|
14
|
|
Long-term
debt including debt due within one year
|
|
$
|
(571
|
)
|
|
$
|
98
|
|
|
|
-
|
|
|
$
|
(473
|
)
|
|
$
|
(820
|
)
|
|
$
|
145
|
|
|
|
-
|
|
|
$
|
(675
|
)
|
(1)
|
Included
in “Other investments” in the
consolidated balance
sheets
.
|
Cost
approximates fair value for all other financial instruments.
The
Corporation enters into foreign exchange forward contracts to hedge various
currency exposures, primarily related to assets and liabilities denominated in
foreign currencies. The primary business objective of the activity is to
optimize the U.S. dollar value of the Corporation’s assets and liabilities.
Assets and liabilities denominated in the same foreign currency are netted, and
only the net exposure is hedged. The Corporation had forward contracts to buy,
sell or exchange foreign currencies that expired in the third quarter of 2009,
and which were immaterial. The Corporation did not designate any derivatives as
hedges at December 31, 2008.
At
September 30, 2009 and December 31, 2008, nonconsolidated affiliates
of the Corporation had hedging activities that were accounted for as cash flow
hedges in accordance with the accounting guidance for derivatives and hedging.
The Corporation’s proportionate share of the hedging results recorded in
accumulated other comprehensive income by the nonconsolidated affiliates is
reported as net hedging results in the Corporation’s consolidated statements of
equity in accordance with the accounting guidance for reporting comprehensive
income.
NOTE
H FAIR VALUE MEASUREMENTS
The
following table summarizes the basis used to measure certain assets at fair
value on a recurring basis in the consolidated balance sheets:
Basis
of Fair Value Measurements
on
a Recurring Basis at
September 30,
2009
In
millions
|
|
Significant
Other Observable Inputs
(Level
2)
|
|
Assets
at fair value:
|
|
|
|
Debt
securities
(1)
|
|
$
|
20
|
|
(1)
|
Included
in “Other investments” in the
consolidated balance
sheets
.
|
Assets
that are measured using significant other observable inputs are primarily valued
by reference to quoted prices of similar assets in active markets, adjusted for
any terms specific to that asset. For all other assets for which observable
inputs are used, fair value is derived through the use of fair value models,
such as a discounted cash flow model or other standard pricing
models.
The
prices for Level 2 items (significant other observable inputs) are based on the
price a dealer would pay for the security or similar securities. Market inputs
are obtained from well-established and recognized vendors of market data and
placed through tolerance/quality checks.
The
following table summarizes the basis used to measure certain assets at fair
value on a nonrecurring basis in the consolidated balance sheets:
Basis
of Fair Value Measurements
on
a Nonrecurring Basis at
September
30, 2009
In
millions
|
|
Significant
Other Unobservable Inputs
(Level
3)
|
|
|
Total
|
|
|
Total
Losses Three Months Ended
Sept.
30,
2009
|
|
|
Total
Losses Nine Months Ended
Sept.
30, 2009
|
|
Assets
at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-lived
assets
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
$
|
(159
|
)
|
As
part of the restructuring plan that was approved on June 30, 2009, the
Corporation shut down certain manufacturing facilities and will divest certain
specialty latex assets resulting from Dow’s acquisition of Rohm and Haas Company
as required by the FTC. As a result, long-lived assets with a carrying value of
$159 million were written down to fair value, less cost to sell, resulting
in an impairment charge of $159 million, which was included in the second
quarter of 2009 restructuring charge (see Note C). The long-lived assets
were valued based on bids received from third parties and using discounted cash
flow analysis based on assumptions that market participants would use. Key
inputs included anticipated revenues, associated manufacturing costs, capital
expenditures and discount, growth and tax rates.
NOTE
I COMMITMENTS AND CONTINGENT
LIABILITIES
Environmental
Matters
Accruals
for environmental matters are recorded when it is probable that a liability has
been incurred and the amount of the liability can be reasonably estimated, based
on current law and existing technologies. At September 30, 2009, the
Corporation had accrued obligations of $79 million for environmental
remediation and restoration costs, including $20 million for the
remediation of Superfund sites. This is management’s best estimate of the costs
for remediation and restoration with respect to environmental matters for which
the Corporation has accrued liabilities, although the ultimate cost with respect
to these particular matters could range up to approximately twice that amount.
Inherent uncertainties exist in these estimates primarily due to unknown
environmental conditions, changing governmental regulations and legal standards
regarding liability, and emerging remediation technologies for handling site
remediation and restoration. At December 31, 2008, the Corporation had
accrued obligations of $67 million for environmental remediation and
restoration costs, including $18 million for the remediation of Superfund
sites. It is the opinion of the Corporation’s management that the possibility is
remote that costs in excess of those disclosed will have a material adverse
impact on the Corporation’s consolidated financial statements.
Litigation
The
Corporation is involved in a number of legal proceedings and claims with both
private and governmental parties. These cover a wide range of matters,
including, but not limited to: product liability; trade regulation; governmental
regulatory proceedings; health, safety and environmental matters; employment;
patents; contracts; taxes; and commercial disputes.
Separately,
the Corporation is and has been involved in a large number of asbestos-related
suits filed primarily in state courts during the past three decades. These suits
principally allege personal injury resulting from exposure to
asbestos-containing products and frequently seek both actual and punitive
damages. The alleged claims primarily relate to products that UCC sold in the
past, alleged exposure to asbestos-containing products located on UCC’s
premises, and UCC’s responsibility for asbestos suits filed against a former
subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are
unable to demonstrate that they have suffered any compensable loss as a result
of such exposure, or that injuries incurred in fact resulted from exposure to
the Corporation’s products.
Influenced
by the bankruptcy filings of numerous defendants in asbestos-related litigation
and the prospects of various forms of state and national legislative reform, the
rate at which plaintiffs filed asbestos-related suits against various companies,
including the Corporation and Amchem, increased in 2001, 2002 and the first half
of 2003. Since then, the rate of filing has significantly abated. The
Corporation expects more asbestos-related suits to be filed against it and
Amchem in the future, and will aggressively defend or reasonably resolve, as
appropriate, both pending and future claims.
Based
on a study completed by Analysis, Research & Planning Corporation (“ARPC”)
in January 2003, the Corporation increased its December 31, 2002
asbestos-related liability for pending and future claims for the 15-year period
ending in 2017 to $2.2 billion, excluding future defense and processing
costs. Since then, the Corporation has compared current asbestos claim and
resolution activity to the results of the most recent ARPC study at each balance
sheet date to determine whether the accrual continues to be appropriate. In
addition, the Corporation has requested ARPC to review the
Corporation’s
historical asbestos claim and resolution activity each November since 2004 to
determine the appropriateness of updating the most recent ARPC
study.
Based
on ARPC’s December 2006 study and the Corporation’s own review of the
asbestos claim and resolution activity, the Corporation decreased the
asbestos-related liability for pending and future claims for the 15-year period
ending in 2021 to $1.2 billion at December 31, 2006.
In
November 2008, the Corporation requested ARPC to review the Corporation’s
historical asbestos claim and resolution activity and determine the
appropriateness of updating ARPC’s December 2006 study. In response to that
request, ARPC reviewed and analyzed data through October 31, 2008. The
resulting study, completed by ARPC in December 2008, stated that the
undiscounted cost of resolving pending and future asbestos-related claims
against UCC and Amchem, excluding future defense and processing costs, through
2023 was estimated to be between $952 million and $1.2 billion.
As in its earlier studies, ARPC provided estimates for a longer period of time
in its December 2008 study, but also reaffirmed its prior advice that forecasts
for shorter periods of time are more accurate than those for longer periods of
time.
In
December 2008, based on ARPC’s December 2008 study and the Corporation’s own
review of the asbestos claim and resolution activity, the Corporation decreased
the asbestos-related liability for pending and future claims by $54 million
to $952 million, which covered the 15-year period ending in 2023, excluding
future defense and processing costs. At December 31, 2008, the
asbestos-related liability for pending and future claims was $934 million.
At December 31, 2008, approximately 21 percent of the recorded
liability related to pending claims and approximately 79 percent related to
future claims.
Based
on the Corporation’s review of 2009 activity, the Corporation determined that no
adjustment to the accrual was required at September 30, 2009. The
Corporation’s asbestos-related liability for pending and future claims was
$857 million at September 30, 2009. Approximately 22 percent of
the recorded liability related to pending claims and approximately
78 percent related to future claims.
At
December 31, 2002, the Corporation increased the receivable for insurance
recoveries related to its asbestos liability to $1.35 billion,
substantially exhausting its asbestos product liability coverage. The insurance
receivable related to the asbestos liability was determined by the Corporation
after a thorough review of applicable insurance policies and the 1985 Wellington
Agreement, to which the Corporation and many of its liability insurers are
signatory parties, as well as other insurance settlements, with due
consideration given to applicable deductibles, retentions and policy limits, and
taking into account the solvency and historical payment experience of various
insurance carriers. The Wellington Agreement and other agreements with insurers
are designed to facilitate an orderly resolution and collection of the
Corporation’s insurance policies and to resolve issues that the insurance
carriers may raise.
In
September 2003, the Corporation filed a comprehensive insurance coverage case,
now proceeding in the Supreme Court of the State of New York, County of New
York, seeking to confirm its rights to insurance for various asbestos claims and
to facilitate an orderly and timely collection of insurance proceeds. This
lawsuit was filed against insurers that are not signatories to the Wellington
Agreement and/or do not otherwise have agreements in place with the Corporation
regarding their asbestos-related insurance coverage, in order to facilitate an
orderly resolution and collection of such insurance policies and to resolve
issues that the insurance carriers may raise. Although the lawsuit is
continuing, through the end of the third quarter of 2009, the Corporation had
reached settlements with several of the carriers involved in this
litigation.
The
Corporation’s receivable for insurance recoveries related to its asbestos
liability was $403 million at September 30, 2009 and December 31,
2008. At September 30, 2009 and December 31, 2008, all of the
receivable for insurance recoveries was related to insurers that are not
signatories to the Wellington Agreement and/or do not otherwise have agreements
in place regarding their asbestos-related insurance coverage.
In
addition to the receivable for insurance recoveries related to the
asbestos-related liability, the Corporation had receivables for defense and
resolution costs submitted to insurance carriers for reimbursement as
follows:
Receivables
for Costs Submitted to Insurance Carriers
|
|
In
millions
|
|
Sept.30,
2009
|
|
|
Dec.
31, 2008
|
|
Receivables
for defense costs
|
|
$
|
21
|
|
|
$
|
28
|
|
Receivables
for resolution costs
|
|
|
231
|
|
|
|
244
|
|
Total
|
|
$
|
252
|
|
|
$
|
272
|
|
The
Corporation expenses defense costs as incurred. The pretax impact for defense
and resolution costs, net of insurance, was $20 million in the third
quarter of 2009 ($14 million in the third quarter of 2008) and
$40 million in the first nine months of 2009 ($30 million in the first
nine months of 2008), and was reflected in “Cost of sales.”
After
a review of its insurance policies, with due consideration given to applicable
deductibles, retentions and policy limits, and after taking into account the
solvency and historical payment experience of various insurance carriers,
existing insurance settlements, and the advice of outside counsel with respect
to the applicable insurance coverage law relating to the
terms
and conditions of its insurance policies, the Corporation continues to believe
that its recorded receivable for insurance recoveries from all insurance
carriers is probable of collection.
The
amounts recorded for the asbestos-related liability and related insurance
receivable described above were based upon current, known facts. However, future
events, such as the number of new claims to be filed and/or received each year,
the average cost of disposing of each such claim, coverage issues among insurers
and the continuing solvency of various insurance companies, as well as the
numerous uncertainties surrounding asbestos litigation in the United States,
could cause the actual costs and insurance recoveries to be higher or lower than
those projected or those recorded.
Because
of the uncertainties described above, management cannot estimate the full range
of the cost of resolving pending and future asbestos-related claims facing the
Corporation and Amchem. Management believes that it is reasonably possible that
the cost of disposing of the Corporation’s asbestos-related claims, including
future defense costs, could have a material adverse impact on the results of
operations and cash flows for a particular period and on the consolidated
financial position of the Corporation.
While
it is not possible at this time to determine with certainty the ultimate outcome
of any of the legal proceedings and claims referred to in this filing,
management believes that adequate provisions have been made for probable losses
with respect to pending claims and proceedings, and that, except for the
asbestos-related matters described above, the ultimate outcome of all known and
future claims, after provisions for insurance, will not have a material adverse
impact on the results of operations, cash flows and consolidated financial
position of the Corporation. Should any losses be sustained in connection with
any of such legal proceedings and claims in excess of provisions provided and
available insurance, they will be charged to income when
determinable.
Purchase
Commitments
At
December 31, 2008, the Corporation had various outstanding commitments for
take-or-pay agreements, with terms extending from one to fifteen years. Such
commitments were not in excess of current market prices. The fixed and
determinable portion of obligations under purchase commitments at
December 31, 2008 is presented in the following table. There have been no
material changes to purchase commitments since December 31,
2008.
Fixed
and Determinable Portion of Take-or-Pay Obligations
at
December 31, 2008
In
millions
|
|
2009
|
|
$
|
13
|
|
2010
|
|
|
14
|
|
2011
|
|
|
6
|
|
2012
|
|
|
4
|
|
2013
|
|
|
4
|
|
2014
and beyond
|
|
|
14
|
|
Total
|
|
$
|
55
|
|
Guarantees
During
the third quarter of 2009, the non-performance guarantees undertaken by the
Corporation for its nonconsolidated affiliate Nippon Unicar Company Limited
expired. In addition, during the third quarter of 2009, the Corporation sold its
ownership interest in OPTIMAL, thereby eliminating all outstanding
non-performance guarantees (see Note D). The Corporation has no outstanding
guarantee obligations at September 30, 2009.
Conditional
Asset Retirement Obligations
The
Corporation has recognized conditional asset retirement obligations related to
asbestos encapsulation as a result of planned demolition and remediation
activities at manufacturing and administrative sites in the United States. The
aggregate carrying amount of conditional asset retirement obligations was
$8 million at September 30, 2009 and $9 million at December 31,
2008. The discount rate used to calculate the Corporation’s asset retirement
obligations was 7.13 percent, unchanged from December 31, 2008. These
obligations are included in the consolidated balance sheets as “Accrued and
other current liabilities.”
The
Corporation has not recognized conditional asset retirement obligations for
which a fair value cannot be reasonably estimated in its consolidated financial
statements. It is the opinion of management that the possibility is remote that
such conditional asset retirement obligations, when estimable, will have a
material adverse impact on the Corporation’s consolidated financial statements
based on current costs.
NOTE
J PENSION AND OTHER POSTRETIREMENT
BENEFITS
Net
Periodic Benefit Cost (Credit) for All Significant Plans
|
|
Three
Months Ended
|
|
Nine
Months Ended
|
In
millions
|
|
Sept.
30,
2009
|
|
Sept.
30,
2008
|
|
Sept.
30,
2009
|
|
Sept.
30,
2008
|
|
Defined
Benefit Pension Plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
Service
cost
|
|
$
|
4
|
|
|
$
|
5
|
|
|
$
|
12
|
|
|
$
|
15
|
|
Interest
cost
|
|
|
56
|
|
|
|
56
|
|
|
|
168
|
|
|
|
168
|
|
Expected
return on plan assets
|
|
|
(75
|
)
|
|
|
(78
|
)
|
|
|
(225
|
)
|
|
|
(234
|
)
|
Amortization
of prior service cost
|
|
|
2
|
|
|
|
2
|
|
|
|
4
|
|
|
|
6
|
|
Amortization
of net loss
|
|
|
-
|
|
|
|
1
|
|
|
|
2
|
|
|
|
2
|
|
Net
periodic benefit credit
|
|
$
|
(13
|
)
|
|
$
|
(14
|
)
|
|
$
|
(39
|
)
|
|
$
|
(43
|
)
|
Other
Postretirement Benefits:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service
cost
|
|
|
-
|
|
|
$
|
1
|
|
|
|
-
|
|
|
$
|
3
|
|
Interest
cost
|
|
$
|
8
|
|
|
|
7
|
|
|
$
|
24
|
|
|
|
21
|
|
Amortization
of prior service credit
|
|
|
-
|
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
(2
|
)
|
Net
periodic benefit cost
|
|
$
|
8
|
|
|
$
|
7
|
|
|
$
|
24
|
|
|
$
|
22
|
|
NOTE
K RELATED PARTY TRANSACTIONS
The
Corporation sells its products to Dow to simplify the customer interface
process. Products are sold to and purchased from Dow at market-based prices in
accordance with the terms of Dow’s long-standing intercompany pricing policies.
The Corporation also procures certain commodities and raw materials through a
Dow subsidiary and pays a commission to that Dow subsidiary based on the volume
and type of commodities and raw materials purchased. The commission expense is
included in “Sundry income (expense) – net” in the consolidated statements of
income. Purchases from that Dow subsidiary were approximately $516 million
in the third quarter of 2009 ($1.1 billion in the third quarter of 2008)
and $1.3 billion in the first nine months of 2009 ($3.2 billion in the
first nine months of 2008).
The
Corporation has a master services agreement with Dow whereby Dow provides
services that include but are not limited to, accounting, legal, treasury
(investments, cash management, risk management, insurance), procurement, human
resources, environmental, health and safety, and business management for UCC.
Under the master services agreement with Dow, for general administrative and
overhead type services that Dow routinely allocates to various businesses, UCC
is charged the cost of those services based on the Corporation’s and Dow’s
relative manufacturing conversion costs. For the first nine months of 2009, this
charge was approximately $16 million, nearly unchanged from the same period
last year (included in “Sundry income (expense) – net”).
For
services that Dow routinely charges based on effort, UCC is charged the cost of
such services on a fully absorbed basis, which includes direct and indirect
costs. Additionally, certain Dow employees are contracted to UCC and Dow is
reimbursed for all direct employment costs of such employees. Management
believes the method used for determining expenses charged by Dow is reasonable.
Dow provides these services by leveraging its centralized functional service
centers to provide services at a cost that management believes provides an
advantage to the Corporation.
The
monitoring and execution of risk management policies related to interest rate
and foreign currency risks, which are based on Dow’s risk management philosophy,
are provided as a service to UCC.
As
part of Dow’s cash management process, UCC is a party to revolving loan
agreements with Dow that have LIBOR-based interest rates with varying
maturities. At September 30, 2009, the Corporation had a note receivable of
$4.5 billion ($3.9 billion at December 31, 2008) from Dow pursuant to
a revolving loan agreement. The Corporation may draw from this note receivable
in support of its daily working capital requirements and, as such, the net
effect of cash inflows and outflows under this revolving loan agreement is
presented in the consolidated statements of cash flows as an operating
activity.
The
Corporation also has a separate revolving credit agreement with Dow that allows
the Corporation to borrow or obtain credit enhancements up to an aggregate of
$1 billion that matures December 30, 2010, pursuant to an amendment
effective as of September 30, 2009. Dow may demand repayment with a 30-day
written notice to the Corporation, subject to certain restrictions. A related
collateral agreement provides for the replacement of certain existing pledged
assets, primarily equity interests in various subsidiaries and joint ventures,
with cash collateral. At September 30, 2009, $862 million
($826 million at December 31, 2008) was available under the revolving
credit agreement. The cash collateral is reported as “Noncurrent receivables
from related companies” in the consolidated balance sheets.
At
December 31, 2008, the Corporation had an insurance receivable of
$47 million reported in “Accounts receivable – Related companies” in the
consolidated balance sheets from its insurer (an affiliate of Dow) for losses
incurred from Hurricanes Katrina, Rita, Gustav and Ike. During the first nine
months of 2009, the Corporation settled the remaining balance of
$45 million of the receivable with its insurer for $43 million with
the balance charged to “Cost of sales.”
The
Corporation received cash dividends from its related company investments of
$5 million in the third quarter of 2009 ($31 million for the first
nine months of 2009). In the first nine months of 2008, the Corporation received
$82 million in dividends from its related company investments, which
included $75 million from Dow International Holdings Company (“DIHC”).
These dividends are included in “Sundry income (expense) – net.”
Union
Carbide Corporation and Subsidiaries
Pursuant
to General Instruction H of Form 10-Q “Omission of Information by Certain
Wholly-Owned Subsidiaries,” this section includes only management's narrative
analysis of the results of operations for the three- and nine-month periods
ended September 30, 2009, the most recent periods, compared with the three-
and nine-month periods ended September 30, 2008, the corresponding periods
in the preceding fiscal year.
References
below to “Dow” refer to The Dow Chemical Company and its consolidated
subsidiaries, except as the context otherwise indicates.
Union
Carbide Corporation’s (the “Corporation” or “UCC”) business activities comprise
components of Dow’s global operations rather than stand-alone operations. Dow
conducts its worldwide operations through global businesses. Because there are
no separable reportable business segments for UCC per the accounting guidance
for disclosures about segments of an enterprise and other related information
and no detailed business information is provided to a chief operating decision
maker regarding the Corporation’s stand-alone operations, the Corporation’s
results are reported as a single operating segment.
The
Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for
forward-looking statements made by or on behalf of the Corporation. This section
covers the current performance and outlook of the Corporation. The
forward-looking statements contained in this section and in other parts of this
document involve risks and uncertainties that may affect the Corporation's
operations, markets, products, services, prices and other factors as more fully
discussed elsewhere and in filings with the U.S. Securities and Exchange
Commission. These risks and uncertainties include, but are not limited to,
economic, competitive, legal, governmental and technological factors.
Accordingly, there is no assurance that the Corporation's expectations will be
realized. The Corporation assumes no obligation to provide revisions to any
forward-looking statements should circumstances change, except as otherwise
required by securities and other applicable laws.
Total
net sales for the third quarter of 2009 were $1,357 million compared with
$1,977 million for the third quarter of 2008, a decrease of
31 percent. Total net sales were $3,686 million for the first nine
months of 2009 compared with $5,967 million for the first nine months of
2008, a decrease of 38 percent.
Net
sales to related companies for the third quarter of 2009 were
$1,322 million compared with $1,929 million for the third quarter of
2008, a decrease of 31 percent. Net sales to related companies were
$3,573 million for the first nine months of 2009 compared with
$5,823 million for the first nine months of 2008, a decrease of
39 percent. Selling prices to Dow, which are based on market prices for the
related products, were lower for most products in the third quarter of 2009
compared with the third quarter of 2008, as prices declined with lower raw
material costs. The most significant declines were reported in ethylene glycols
and polyethylene which experienced lower prices and lower volume. Vinyl acetate
monomer, oxo products, polyglycols and surfactants all reported higher sales
compared with the third quarter of 2008 as increased volume more than offset
lower prices. Prices for most products were also lower for the first nine months
of 2009 compared with the first nine months of 2008 with ethylene glycols,
propylene products and polyethylene experiencing the most significant price
declines. The lower prices on a year-to-date basis compared with the prior year
also reflected declines in feedstock and energy and raw material costs. The
increase in sales volume for ethyleneamines, vinyl acetate monomer and oxo
products for the first nine months of 2009 compared with the first nine months
of 2008 was more than offset by the lower sales demand for other products
.
Cost
of sales decreased 41 percent from $1,942 million in the third quarter
of 2008 to $1,145 million in the third quarter of 2009, principally due to
lower feedstock and energy costs, lower sales volume and cost control measures.
On a year-to-date basis, cost of sales decreased 44 percent from
$5,785 million in the first nine months of 2008 to $3,224 million in
the first nine months of 2009, again reflecting lower feedstock and energy costs
and lower sales volume.
Equity
in earnings of nonconsolidated affiliates was $14 million in the third
quarter of 2009 compared with $55 million in the third quarter of 2008. The
OPTIMAL Group of Companies (“OPTIMAL”) reported a significant decline in
earnings in the third quarter of 2009 compared with the third quarter of 2008.
For the first nine months of 2009 equity in earnings of nonconsolidated
affiliates were $20 million compared with $172 million for the first
nine months of 2008, as the Corporation’s joint ventures were also impacted by
the severe recessionary environment.
Sundry
income (expense) – net includes a variety of income and expense items such as
the gain or loss on foreign currency exchange, dividends from investments,
commissions, charges for management services provided by Dow, and gains and
losses on sales of investments and assets. Sundry income (expense) – net for the
third quarter of 2009 was income of $320 million compared with expense of
$18 million for the third quarter of 2008. Sundry income (expense) - net
was favorably impacted in the third quarter of 2009 by a pretax gain of
$328 million on the sale of the Corporation’s ownership
interest
in OPTIMAL (See Note D to the Consolidated Financial Statements). Year to date,
sundry income (expense) - net was income of $322 million compared
with income of $38 million for the first nine months of 2008. Sundry income
(expense) - net for the first nine months of 2008 was favorably
impacted by a dividend of $75 million from Dow International Holdings
Company (“DIHC”) in the first quarter of 2008 (see Note K to the Consolidated
Financial Statements).
Interest
income was $21 million in the third quarter of 2009 compared with
$24 million in the third quarter of 2008. Year to date, interest income was
$31 million, down from $82 million in the first nine months of 2008.
Interest income was lower in 2009 compared with the same periods of last year
due to lower interest rates. Interest expense and amortization of debt discount
was $8 million in the third quarter of 2009 compared with $12 million
in the third quarter of 2008. In the first nine months of 2009, interest expense
and amortization of debt discount was $32 million compared with
$37 million for the first nine months of 2008.
The
Corporation reported a provision for income taxes of $222 million in the
third quarter of 2009 due primarily to the sale of its ownership interest in
OPTIMAL. For the first nine months of 2009, the provision for income taxes was
$183 million. The effective tax rate fluctuates based on, among other
factors, where income is earned, the level of after-tax income from joint
ventures, dividends received from investments in related companies and the level
of income relative to tax credits available. The effective tax rate for the
first nine months of 2009 was 30.9 percent compared with 24.9 percent
for the same period last year.
The
Corporation reported net income of $326 million for the third quarter of
2009 compared with $81 million for the third quarter of 2008, and net
income for the first nine months of 2009 of $410 million compared with
$281 million for the first nine months of 2008. Excluding the pretax gain
from the Corporation’s sale of its ownership interest in OPTIMAL, the results
for the first nine months of 2009 reflected the continuing global recession, as
lower demand continued to put downward pressure on prices, which more than
offset lower feedstock and energy costs, resulting in lower
margins.
On
July 31, 2009, Dow entered into a definitive agreement that included the sale of
certain specialty latex assets of the Corporation, located in the United States,
Canada, Puerto Rico, and Mexico, as required by the United States Federal Trade
Commission (“FTC”) for the approval of Dow’s acquisition of Rohm and Haas
Company. An impairment charge of $114 million for these assets was
recognized in the second quarter 2009 restructuring charge (see Note C to the
Consolidated Financial Statements). The transaction is subject to approval by
the FTC and other customary closing conditions and is expected to close by the
end of 2009.
Recent
Accounting Guidance
See
Note B to the Consolidated Financial Statements for a summary of recent
accounting guidance. In addition, see Note H to the Consolidated Financial
Statements for the Corporation’s disclosures about fair value measurements.
The sensitivity
of fair value measurements is immaterial relative to the assets and liabilities
measured at fair value, as well as to the total equity of the
Corporation.
Critical
Accounting Policies
The
preparation of financial statements and related disclosures in conformity with
accounting principles generally accepted in the United States of America
requires management to make judgments, assumptions and estimates that affect the
amounts reported in the Consolidated Financial Statements and accompanying
notes. Note A to the Consolidated Financial Statements in the Corporation’s
Annual Report on Form 10-K for the year ended December 31, 2008 (“2008
10-K”) describes the significant accounting policies and methods used in the
preparation of the Consolidated Financial Statements. The Corporation’s critical
accounting policies that are impacted by judgments, assumptions and estimates
are described in Management’s Discussion and Analysis of Financial Condition and
Results of Operations in the Corporation’s 2008 10-K. Since December 31,
2008, there have been no material changes in the Corporation’s critical
accounting policies.
Asbestos-Related
Matters
Introduction
The
Corporation is and has been involved in a large number of asbestos-related suits
filed primarily in state courts during the past three decades. These suits
principally allege personal injury resulting from exposure to
asbestos-containing products and frequently seek both actual and punitive
damages. The alleged claims primarily relate to products that UCC sold in the
past, alleged exposure to asbestos-containing products located on UCC’s
premises, and UCC’s responsibility for asbestos suits filed against a former
subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are
unable to demonstrate that they have suffered any compensable loss as a result
of such exposure, or that injuries incurred in fact resulted from
exposure to the Corporation’s products.
Influenced
by the bankruptcy filings of numerous defendants in asbestos-related litigation
and the prospects of various forms of state and national legislative reform, the
rate at which plaintiffs filed asbestos-related suits against
various
companies,
including the Corporation and Amchem, increased in 2001, 2002 and the first half
of 2003. Since then, the rate of filing has significantly abated. The
Corporation expects more asbestos-related suits to be filed against it and
Amchem in the future, and will aggressively defend or reasonably resolve, as
appropriate, both pending and future claims.
The
table below provides information regarding asbestos-related claims filed against
the Corporation and Amchem:
|
|
2009
|
|
|
2008
|
|
Claims
unresolved at January 1
|
|
|
75,706
|
|
|
|
90,322
|
|
Claims
filed
|
|
|
6,379
|
|
|
|
8,357
|
|
Claims
settled, dismissed or otherwise resolved
|
|
|
(6,728
|
)
|
|
|
(15,856
|
)
|
Claims
unresolved at September 30
|
|
|
75,357
|
|
|
|
82,823
|
|
Claimants
with claims against both UCC and Amchem
|
|
|
24,328
|
|
|
|
26,184
|
|
Individual
claimants at September 30
|
|
|
51,029
|
|
|
|
56,639
|
|
Plaintiffs’
lawyers often sue dozens or even hundreds of defendants in individual lawsuits
on behalf of hundreds or even thousands of claimants. As a result, the damages
alleged are not expressly identified as to UCC, Amchem or any other particular
defendant, even when specific damages are alleged with respect to a specific
disease or injury. In fact, there are no personal injury cases in which only the
Corporation and/or Amchem are the sole named defendants. For these reasons and
based upon the Corporation’s litigation and settlement experience, the
Corporation does not consider the damages alleged against it and Amchem to be a
meaningful factor in its determination of any potential asbestos-related
liability.
Estimating
the Liability
Based
on a study completed by Analysis, Research & Planning Corporation (“ARPC”)
in January 2003, the Corporation increased its December 31, 2002
asbestos-related liability for pending and future claims for the 15-year period
ending in 2017 to $2.2 billion, excluding future defense and processing
costs. Since then, the Corporation has compared current asbestos claim and
resolution activity to the results of the most recent ARPC study at each balance
sheet date to determine whether the accrual continues to be appropriate. In
addition, the Corporation has requested ARPC to review the Corporation’s
historical asbestos claim and resolution activity each November since
2004 to determine the appropriateness of updating the most recent ARPC
study.
Based
on ARPC’s December 2006 study and the Corporation’s own review of the
asbestos claim and resolution activity, the Corporation decreased the
asbestos-related liability for pending and future claims for the 15-year period
ending in 2021 to $1.2 billion at December 31, 2006.
In
November 2008, the Corporation requested ARPC to review the Corporation’s
historical asbestos claim and resolution activity and determine the
appropriateness of updating ARPC’s December 2006 study. In response to that
request, ARPC reviewed and analyzed data through October 31, 2008. The
resulting study, completed by ARPC in December 2008, stated that the
undiscounted cost of resolving pending and future asbestos-related claims
against UCC and Amchem, excluding future defense and processing costs, through
2023 was estimated to be between $952 million and $1.2 billion. As in
its earlier studies, ARPC provided estimates for a longer period of time in its
December 2008 study, but also reaffirmed its prior advice that forecasts for
shorter periods of time are more accurate than those for longer periods of
time.
In
December 2008, based on ARPC’s December 2008 study and the Corporation’s own
review of the asbestos claim and resolution activity, the Corporation decreased
the asbestos-related liability for pending and future claims by $54 million
to $952 million, which covered the 15-year period ending in 2023, excluding
future defense and processing costs. At December 31, 2008, the
asbestos-related liability for pending and future claims was $934 million.
At December 31, 2008, approximately 21 percent of the recorded
liability related to pending claims and approximately 79 percent related to
future claims.
Based
on the Corporation’s review of 2009 activity, the Corporation determined that no
adjustment to the accrual was required at September 30, 2009. The
Corporation’s asbestos-related liability for pending and future claims was
$857 million at September 30, 2009. Approximately 22 percent of
the recorded liability related to pending claims and approximately
78 percent related to future claims.
Defense
and Resolution Costs
The
following table provides information regarding defense and resolution costs
related to asbestos-related claims filed against the Corporation and
Amchem:
Defense
and Resolution Costs
|
|
Nine
Months Ended
|
|
|
Aggregate
Costs
|
|
In
millions
|
|
Sept.
30,
2009
|
|
|
Sept.
30,
2008
|
|
|
to
Date as of
Sept.
30, 2009
|
|
Defense
costs
|
|
$
|
40
|
|
|
$
|
37
|
|
|
$
|
665
|
|
Resolution
costs
|
|
$
|
77
|
|
|
$
|
90
|
|
|
$
|
1,463
|
|
The
average resolution payment per asbestos claimant and the rate of new claim
filings has fluctuated since the beginning of 2001. The Corporation’s management
expects such fluctuation to continue based upon a number of factors, including
the number and type of claims settled in a particular period, the jurisdictions
in which such claims arose and the extent to which any proposed legislative
reform related to asbestos litigation is being considered.
The
Corporation expenses defense costs as incurred. The pretax impact for defense
and resolution costs, net of insurance, was $20 million in the third
quarter of 2009 ($14 million in the third quarter of 2008) and
$40 million in the first nine months of 2009 ($30 million in the first
nine months of 2008), and was reflected in “Cost of sales.”
Insurance
Receivables
At
December 31, 2002, the Corporation increased the receivable for insurance
recoveries related to its asbestos liability to $1.35 billion,
substantially exhausting its asbestos product liability coverage. The insurance
receivable related to the asbestos liability was determined after a thorough
review of applicable insurance policies and the 1985 Wellington Agreement, to
which the Corporation and many of its liability insurers are signatory parties,
as well as other insurance settlements, with due consideration given to
applicable deductibles, retentions and policy limits, and taking into account
the solvency and historical payment experience of various insurance carriers.
The Wellington Agreement and other agreements with insurers are designed to
facilitate an orderly resolution and collection of the Corporation’s insurance
policies and to resolve issues that the insurance carriers may
raise.
In
September 2003, the Corporation filed a comprehensive insurance coverage case,
now proceeding in the Supreme Court of the State of New York, County of New
York, seeking to confirm its rights to insurance for various asbestos claims and
to facilitate an orderly and timely collection of insurance proceeds. This
lawsuit was filed against insurers that are not signatories to the Wellington
Agreement and/or do not otherwise have agreements in place with the Corporation
regarding their asbestos-related insurance coverage, in order to facilitate an
orderly resolution and collection of such insurance policies and to resolve
issues that the insurance carriers may raise. Although the lawsuit is
continuing, through the end of the third quarter of 2009, the Corporation had
reached settlements with several of the carriers involved in this
litigation.
The
Corporation’s receivable for insurance recoveries related to the asbestos
liability was $403 million at September 30, 2009 and December 31,
2008. At September 30, 2009 and December 31, 2008, all of the
receivable for insurance recoveries was related to insurers that are not
signatories to the Wellington Agreement and/or do not otherwise have agreements
in place regarding their asbestos-related insurance coverage.
In
addition to the receivable for insurance recoveries related to the
asbestos-related liability, the Corporation had receivables for defense and
resolution costs submitted to insurance carriers for reimbursement as
follows:
Receivables
for Costs Submitted to Insurance Carriers
|
|
In
millions
|
|
Sept. 30,
2009
|
|
|
Dec.
31, 2008
|
|
Receivables
for defense costs
|
|
$
|
21
|
|
|
$
|
28
|
|
Receivables
for resolution costs
|
|
|
231
|
|
|
|
244
|
|
Total
|
|
$
|
252
|
|
|
$
|
272
|
|
After
a review of its insurance policies, with due consideration given to applicable
deductibles, retentions and policy limits, and after taking into account the
solvency and historical payment experience of various insurance carriers,
existing insurance settlements, and the advice of outside counsel with respect
to the applicable insurance coverage law relating to the terms and conditions of
its insurance policies, the Corporation continues to believe that its recorded
receivable for insurance recoveries from all insurance carriers is probable of
collection.
Summary
The
amounts recorded for the asbestos-related liability and related insurance
receivable described above were based upon current, known facts. However, future
events, such as the number of new claims to be filed and/or received each year,
the average cost of disposing of each such claim, coverage issues among insurers
and the continuing solvency of various insurance companies, as well as the
numerous uncertainties surrounding asbestos litigation in the United States,
could cause the actual costs and insurance recoveries to be higher or lower than
those projected or those recorded.
Because
of the uncertainties described above, management cannot estimate the full range
of the cost of resolving pending and future asbestos-related claims facing the
Corporation and Amchem. Management believes that it is reasonably possible that
the cost of disposing of the Corporation’s asbestos-related claims, including
future defense costs, could have a material adverse impact on the Corporation’s
results of operations and cash flows for a particular period and on the
consolidated financial position of the Corporation.
Omitted
pursuant to General Instruction H of Form 10-Q.
Evaluation
of Disclosure Controls and Procedures
As
of the end of the period covered by this Quarterly Report on Form 10-Q, the
Corporation carried out an evaluation, under the supervision and with the
participation of the Corporation’s Disclosure Committee and the Corporation’s
management, including the Chief Executive Officer and the Chief Financial
Officer, of the effectiveness of the design and operation of the Corporation’s
disclosure controls and procedures pursuant to paragraph (b) of Exchange Act
Rules 13a-15 or 15d-15. Based upon that evaluation, the Chief Executive Officer
and the Chief Financial Officer concluded that the Corporation’s disclosure
controls and procedures were effective.
Changes
in Internal Control Over Financial Reporting
There
were no changes in the Corporation’s internal control over financial reporting
identified in connection with the evaluation required by paragraph (d) of
Exchange Act Rules 13a-15 or 15d-15 that was conducted during the last fiscal
quarter that have materially affected, or are reasonably likely to materially
affect, the Corporation’s internal control over financial
reporting.